We are live on ! Find out more
LDRS

Innovator IBD ETF Leaders ETF
LDRS

Delisted

LDRS was delisted on the 13th of August, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Innovator IBD ETF Leaders ETF in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $950K → $0 (-$950K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
–
Holders Change
-3
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$860K
2
Osaic Holdings
Osaic Holdings
Arizona
-$67K
3
UBS Group
UBS Group
Switzerland
-$23K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
– -$860K -30,912 Closed
Osaic Holdings
2
Osaic Holdings
Arizona
– -$67K -2,400 Closed
UBS Group
3
UBS Group
Switzerland
– -$23K -830 Closed

LDRS Hedge Fund Activity: Q3 2021 in Review

0 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q3 2021, worth a combined $0 — down 100% from $950K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of LDRS and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Susquehanna International Group, exiting entirely with an estimated $860K sold.

  • 0 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q3 2021, down from 3 in Q2 2021.
  • Funds reported $0 of Innovator IBD ETF Leaders ETF stock for Q3 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Innovator IBD ETF Leaders ETF positions in Q3 2021 and 3 closed out, a net change of -3 holders.
  • The largest Innovator IBD ETF Leaders ETF seller in Q3 2021 was Susquehanna International Group, an estimated $860K sold.

Based on aggregated 13F filings for Q3 2021.